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Previous studies have shown that the pial microcirculation remodeling improves
neurological outcome after middle cerebral artery occlusion (MCAO), accompanied by
higher expression of vascular endothelial growth factor (VEGF) and endothelial nitric
oxide synthase (eNOS), modulating in vivo angiogenesis. This study was aimed to
assess the effects of bone marrow mesenchymal stem cells (BM-MSCs) infused after
MCAO on rat pial microcirculation. Animals were subjected to 2 h MCAO followed
by BM-MSCs infusion into internal carotid artery. Pial microcirculation was observed
at different reperfusion times by fluorescence microscopy. Geometric characteristics
of arteriolar networks, permeability increase, leukocyte adhesion, perfused capillary
density, VEGF, and endothelial nitric oxide synthase (e-NOS) expression were evaluated.
Green fluorescent protein (GFP)-BM-MSCs were used to evaluate their distribution
and cell phenotype development during reperfusion. BM-MSCs stimulated a geometric
rearrangement of pial networks with formation of new anastomotic vessels sprouting
from preexistent arterioles in the penumbra at 7–14–28 days of reperfusion. At the same
time VEGF and eNOS expression increased. GFP-BM-MSCs appear to be involved in
endothelial and smooth muscle cell programming in the infarcted area. In conclusion,
transient MCAO induced pial vascular remodeling characterized by arteriolar anastomotic
arcades (originated from preexistent arterioles in penumbra area) able to overlap the
ischemic core supplying blood to the neuronal tissue. BM-MSCs appear to accelerate
angiogenic processes facilitating new vessel formation; this mechanism was promoted
by an increase in VEGF and eNOS expression.
Keywords: cerebral microcirculation, stroke, bone marrow mesenchymal stem cells, angiogenesis,
endothelium-derived factors
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Introduction
Pial microcirculation remodeling improves neurological
outcome after middle cerebral artery occlusion (MCAO),
accompanied by higher expression of vascular endothelial
growth factor (VEGF) and endothelial nitric oxide synthase
(eNOS), modulating in vivo angiogenesis, as previously
observed (Li et al., 2002; Lapi et al., 2008, 2013; Komatsu et al.,
2010). Bone marrow mesenchymal stem cells (BM-MSCs), a
heterogeneous population of plastic-adherent cells, have been
successfully used for the treatment of experimental stroke (Li
et al., 2002). Breakdown of the blood-brain barrier (BBB) has
been proven to occur after ischemia. In normal rat brain it has
been demonstrated the integrity of the BBB, using Evans blue
extravasation; conversely intense blue leakage was observed in
the infarcted lesions at 7, 14, and 28 days after MCAO (Komatsu
et al., 2010). Interestingly, BM-MSCs migrate selectively into
damaged brain areas after intravenous injection at an early
phase after ischemia (Honma et al., 2006; Chavakis et al., 2008).
Specific molecular signals, such as stromal cell-derived factor-1
(SDF-1/CXCR4) intracellular signaling, adhesion molecules
and proteases are involved in the interaction of BM-MSCs
to reach, recognize, and function in cerebral ischemic tissue
(Chavakis et al., 2008). These BM-MSCs have an inhibitory
effect on T-cell proliferation triggered by cellular or humoral
stimuli (Di Nicola et al., 2002), while under specific conditions,
BM-MSCs can be induced to in vitro differentiate into multiple
cell types, including neurons (Qi et al., 2010; Shichinohe et al.,
2010) and endothelial cells (Shen et al., 2007). The ability to
form capillaries in semisolid medium was tested with an in vitro
angiogenesis kit; the cells were cultivated in the presence of
two different concentrations of VEGF and once without VEGF.
When cultured in presence of endothelial growth supplements,
the cells start to express endothelial markers (Oswald et al.,
2004).
Kinnaird et al. have shown that mesenchymal stem cells
express a wide spectrum of angiogenic growth factors
and may stimulate collateral vessel formation, by paracrine
mechanisms after the injection of these cells into the adductor
muscles of the ischemic hindlimb. They found that local
production of basic Fibroblast Growth Factor (bFGF) and
VEGF increased in BM-MSCs injected tissue and documented
colocalization of BM-MSCs and VEGF (Kinnaird et al.,
2004).
Although a plethora of stem cell studies are being translated
into clinical practice, it is important to gain insights into the
mechanisms of revascularization to optimize these approaches
after stroke. Moreover, recent in vitro studies have shown BM-
MSCs transplantation after MCAO causes angiogenesis in the
cortex (Pavlichenko et al., 2008; Komatsu et al., 2010; Guo
et al., 2012; Du et al., 2014). The main techniques used to
detect the presence of BM-MSCs in the brain and the eventual
angiogenesis are based on immunofluorescent staining, Western
blotting, and RT-PCR analysis. Up to day, however, there
are no experimental data demonstrating the in vivo effects of
cerebral neovascularization induced by post-stroke BM-MSCs
intra-arterial administration.
Therefore, this study was aimed to evaluate whether these
cells can accelerate the in vivo physiological mechanism of
remodeling and to define BM-MSCs potential therapeutic
benefits to generate blood vessels in rat pial microcirculation,
at various times after induction of transient middle cerebral
artery (MCA) occlusion. In particular, our purpose was to
evaluate the geometric characteristics of pial arterioles as well
as microvascular permeability, leukocyte adhesion to venular
walls and capillary perfusion after ischemia-reperfusion injury.
Moreover, we infused in vivo green fluorescent protein (GFP),
BM-MSCs in rats submitted to transient MCA occlusion to
follow their fate at different time intervals of reperfusion by
confocal microscopy.
Materials and Methods
All experiments were carried out according to the Guide for
the Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No. 85-23,
revised 1996) and to institutional rules for the care and handling
of experimental animals. The protocol was approved by the
“Federico II” University of Naples Ethical Committee.
Isolation and Identification of BM-MSCs and
GFP-BM-MSCs
The BM-MSCs and GFP-BM-MSCs were isolated under sterile
conditions from 8 to 10 week-old maleWistar rats and transgenic
rats expressing the enhanced green fluorescent protein (GFP),
respectively, as previously described (Lee et al., 2004; Sugiyama
et al., 2011). Rats were killed by cervical dislocation and bone
marrow was harvested from tibias and femurs. The marrow
plug was flushed by introducing into marrow cavity saline
solution. The cells were seeded at the density of 300,000–500,000
cells/cm2 in tissue culture flasks. BM-MSCs were isolated by
plastic adherence and expanded in standard medium DMEM
(Dulbecco’s Modified Eagle’s Medium) supplemented with 10%
fetal bovine serum (FBS) and 100 U/mL penicillin G at 37◦C and
5% CO2 for 3 days. The medium was then replaced with fresh
medium and the adherent cells were grown to 90% confluence. As
the culture approached confluence, the cells were detached with
0.05% Trypsin and subcultured.
To confirm the mesenchymal nature of the cells obtained,
osteogenic, and adipogenic differentiation capability were
assessed by adding to the cultures appropriate differentiation
media according to the manufacturer instructions (Invitrogen,
StemPro R© Osteogenesis Differentiation, Stem Pro R©
Adipogenesis Differentiation Kit). In addition, the following
surface markers antigens were evaluated by flow cytometry at
different passages, analyzing the expression of CD44, CD105,
CD166, CD90, CD34, and CD45 (Lee et al., 2003; Shichinohe
et al., 2011). The cells harvested at 3–5 passages were used as
BM-MSCs or GFP-BM-MSCs grafts (Raimondo et al., 2006;
Gallo et al., 2007).
Experimental Groups
Rats were randomly divided into 10 groups: (a) sham-operated
animals (S group, n = 15) receiving the same surgical procedures
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as the other experimental groups without MCAO; (b) ischemic
group, submitted to 2 h MCAO and receiving 300µl cell-free
phosphated buffer saline (PBS) solution; these animals were
observed after 1 day (I-1R group, n = 5), 7 days (I-7R group,
n = 15), 14 days (I-14R group, n = 15) and 28 days (I-28R group,
n = 15) of reperfusion. (c) BM-MSCs-treated group subjected to
2 hMCAO and then infused with BM-MSCs (300µl PBS solution
containing 106 cells); these animals were observed at: 1 day (I-
MSCs-1R group, n = 5), 7 days (I-MSCs-7R group, n = 15),
14 days (I-MSCs-14R group, n = 15), and 28 days (I-MSCs-28R
group, n = 15) of reperfusion. (d) The fourth group, GFP-BM-
MSCs-treated group, was subjected to 2 h MCAO and infused
with GFP-BM-MSCs (300µl PBS solution containing 106 cells);
these rats were studied after 1 (I-GFP-1R, n = 5), 7 (I-GFP-7R,
n = 12), 14 (I-GFP-14R, n = 12), and 28 days (I-GFP-28R,
n = 12) of reperfusion. (e) The last group, MEDIUM-treated
group, was subjected to 2 h MCAO and infused with BM-MSCs
culture standard medium, DMEM [(Dulbecco’s Modified Eagle’s
Medium) supplemented with 10% fetal bovine serum (FBS) and
100 U/mL penicillin G. The culture medium, maintained at 37◦C
and 5% CO2 for 3 days, was filtered with 1.2µm pore membrane
(GVS, Filter Technology, Inc., Indianapolis, IN, USA). These
animals were studied after 1 (I-M-1R, n = 5), 7 (I-M-7R, n =
5), 14 (I-M-14R, n = 5), and 28 days (I-M-28R, n = 5) of
reperfusion.
Moreover, six rats belonging to S, I-7R, I-14R, I-28R, I-
MSCs-7R, I-MSCs-14R, and I-MSCs-28R groups were utilized
to determine neuronal damage by 2,3,5-triphenyltetrazolium
chloride (TTC) Staining (n = 3) and by Neuronal Nuclei (NeuN)
immunohistochemical Staining (n = 3).
Animal Model
Adult maleWistar rats (Charles River), weighing 250–300 g, were
used. MCAO was induced by intraluminal filament technique, as
previously described (Longa et al., 1989).
Briefly, rats were anesthetized with intraperitoneal injection
of alpha-chloralose (60mg/kg b.w.); the left common carotid
artery (CCA), external carotid artery (ECA), and internal carotid
artery (ICA) were exposed. Subsequently, ECA was cut with
microscissors; heparinized 4-0 nylon filament was inserted into
ECA and advanced into ICA about 20mm blocking the origin of
the middle cerebral artery. To determine the perfusion decrease
during MCAO, microvascular blood flow was measured by
laser Doppler perfusion monitoring (LDPM) on the skull of
all animals by a Perimed PF5001 flowmeter, using a probe
(407; Perimed, Sweden) attached to the bone. The sampling
rate was 32Hz and blood flow was expressed as Perfusion
Units (PU). After 2 h occlusion, the filament was withdrawn
and 106 of BM-MSCs or GFP-BM-MSCs in treated groups or
cell-free PBS in ischemic animals were infused by insertion
of a catheter; immediately after the infusion, the incision was
sutured. Successively, the rats were allowed to recover from
surgical intervention with free access to pellets and water. After
1, 7, 14, and 28 days of reperfusion the animals were re-
anesthetized, intubated and mechanically ventilated with room
air and supplemental oxygen. A catheter was placed in the left
femoral artery for arterial blood pressure recording and blood
gases sampling; another one was placed in the right femoral vein
for injection of the fluorescent tracers [fluorescein isothiocyanate
bound to dextran, molecular weight 70 KDa (FD 70), 50 mg/100
g b.w. i.v. as 5% wt./vol solution in 5min, and rhodamine 6G
to label leukocytes 1mg/100 g b.w. in 0.3mL] and for additional
anesthesia. Blood gas measurements were carried out on arterial
blood samples withdrawn from arterial catheter at 30min time
period intervals (ABL5; Radiometer, Copenhagen, Denmark).
Mean arterial blood pressure (MABP), heart rate, respiratory
CO2 and blood gases values were recorded and maintained stable
within physiological ranges. Rectal temperature was monitored
and preserved at 37.0 ± 0.5◦C with a heating pad, where the rats
were secured.
Surgical Procedure to Observe Pial Vessels
To visualize pial microcirculation, a closed cranial window (4 ×
5mm) was implanted above the left parietal cortex (posterior
1.5mm to Bregma; lateral, 3mm to the midline) (Ngai et al.,
1988). Successively, a second closed cranial window was fixed,
obeying the same spatial coordinates as the previous one,
above the right parietal cortex to visualize the contralateral pial
microcirculation. The dura mater was gently removed and a
150µm-thick quartz microscope coverglass was sealed to the
bone with dental cement. The window inflow and outflow
were assured by two needles secured in the dental cement of
the window so that the brain parenchyma was continuously
superfused with artificial cerebrospinal fluid (aCSF). The rate of
superfusion was 0.5mL/min controlled by a peristaltic pump.
During superfusion the intracranial pressure was maintained
at 5 ± 1mmHg and measured by a Pressure Transducer
connected to a computer. The composition of the aCSF was:
119.0mM NaCl, 2.5mM KCl, 1.3mM MgSO4·7H2O, 1.0mM
NaH2PO4, 26.2mM NaHCO3, 2.5mM CaCl2, and 11.0mM
glucose (equilibrated with 10% O2, 6% CO2, and 84% N2; pH
7.38 ± 0.02) (Ngai et al., 1988). At the end of the experiments,
the animals of ischemic and BM-MSCs treated groups were
euthanized; the specimen of ipsilateral cortex and striatum were
isolated to quantify the expression of VEGF, e-NOS, p-eNOS, n-
NOS, and i-NOS proteins known to participate to remodeling
processes.
Fluorescence Microscopy and Microvascular
Parameter Assessment
Pial microcirculation was visualized with a fluorescence
microscope, as previously reported. The arteriolar network was
mapped by stop-frame images and pial arterioles were classified
according to Strahler’s method, modified according to diameter
(Kassab et al., 1993). The arterioles were classified from the
smallest ones, assigned order 1, which gave origin to capillaries
(order 0), up to the largest arterioles in the preparations, assigned
order 4. When two vessels of the same order joined, the parent
vessel was assigned the next higher order. If two daughter
vessels were of different orders, the parent vessel retained the
higher of the two orders. The procedure of the pial arteriole
classification was previously described (Lapi et al., 2008).
Moreover, a “connectivity matrix” was calculated to clarify the
number and order of daughter arterioles spreading from parent
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vessels. Briefly, order n vessels may spring from orders n + 1,
n + 2, . . . . vessels, the component of which in row n and column
m was the ratio of the total number of elements of order n sprung
from elements in orderm (see Appendix for more details).
Penetrating pial arterioles, i.e., pial arterioles supplying
cerebral cortex outer layers, were enumerated under baseline
conditions and at the different times of reperfusion by computer-
assisted method. The analysis was carried out counting the pial
arterioles penetrating into the cortex subsurface in a region of
interest (ROI) of 400µm2 (Shih et al., 2009).
The increase in permeability was calculated as normalized
gray levels (NGL): NGL = (I–Ir)/Ir, where Ir is the average
baseline gray level at the end of vessel filling with fluorescence
(average of five windows located outside the blood vessels with
the same windows being used throughout the experimental
procedure), and I is the same parameter at the end of reperfusion.
Gray levels ranging from 0 to 255 were determined by the
MIP Image program in five regions of interest (ROI) measuring
50µm2 (10x objective). The same location of ROI during
recordings along the microvascular networks was provided by
a computer-assisted device for XY movement of the microscope
table.
Adherent leukocytes (i.e., cells on vessel walls that did
not move over a 30-s observation period) were quantified in
terms of number/100µm of venular length (v.l.)/30 s using
higher magnification (32x, microscope objective). In each
experimental group 45 venules were studied. The perfused
capillary density (PCD) was measured by computerized method
(MIP Image, CNR, Pisa) in an area of 150µm2 and expressed as
cm/cm2 = cm−1.
MABP (Viggo-Spectramed P10E2 trasducer—Oxnard, CA—
connected to a catheter in the femoral artery) and heart rate
were monitored with a Gould Windograf recorder (model 13-
6615-10S, Gould, OH, USA). Data were recorded and stored in
a computer. Blood gas measurements (arterial partial pressure
of O2 and CO2 and pH) were carried out on arterial blood
samples withdrawn from arterial catheter at 30min intervals
(ABL5; Radiometer, Copenhagen, Denmark).
Western Blot Analysis
Proteins were extracted from ipsilateral cortex and striatum
tissues (Matrone et al., 2004), and their concentration was
determined using the Bio-Rad protein assay kit. Equal amounts
of proteins were separated by SDS-PAGE under reducing
conditions, and then transferred to polyvinylidene difluoride
membranes (PVDF, Invitrogen, USA). The immunoblot was
blocked, incubated with specific antibodies at 4◦C overnight,
washed, and then incubated with a 1:2000 dilution of HRP
(horseradish peroxidase)-conjugated IgG secondary antibody
(GE-Healthcare, UK). Blots were washed again and visualized
by ECL system (GE-Healthcare, UK). The optical density of
the bands was determined by Chemi Doc Imaging System
(Bio-Rad). By incubating PVDF membrane in parallel with β-
tubulin antibody (1:5000) normalization of results was obtained.
Specific antibodies were: mouse monoclonal anti-VEGF (1:200),
rabbit polyclonal anti-eNOS (1:500), rabbit polyclonal anti-
phosphorylated eNOS (Ser 1177) (1:250), mouse monoclonal
anti nNOS (1:1000) and rabbit polyclonal anti iNOS (1:500).
Antibodies were purchased from Santa Cruz Biotechnology,
Santa Cruz, CA, USA.
Immunohistochemistry
Immunohistochemistry was carried out, as previously described
(Bederson et al., 1986). The GFP-BM-MSCs treated rats were
deeply anesthetized and perfused via the left ventricle of the heart
with 0.9% NaCl solution followed by 4% paraformaldehyde. The
brains were removed and sectioned coronally at 60µm on a
vibratome. In these animals (n = 3), we observed the distribution
of GFP-positive cells in the tissue. In the remaining animals, after
blocking, sections were incubated with the following primary
antisera: rabbit polyclonal anti-CD31 (1:200), (n = 3) and
rabbit polyclonal anti-von Willebrand factor (vWF) (1:200)
(n = 3), specific markers of endothelial cells, and anti-
α-SMA (1:500), (n = 3), mouse anti-actin smooth muscle
monoclonal antibody. Subsequently, sections were incubated in
a mixture of the fluorescent red-labeled secondary antibodies
(Alexa 594-conjugated antimouse/antirabbit IgG). Images were
observed using a Zeiss LSM510 META/laser scanning confocal
microscope. Single images were taken with an optical thickness
of 0.7µm and a resolution of 1024 × 1024. To quantify the
number of BM -derived endothelial cells (ECs), we analyzed eight
representative sections per animal stained with antibodies against
CD-31 or von Willebrand factor. In similar fashion, we analyzed
smooth muscle cells using antibodies against α-SMA, colocalized
with GFP signal. We then calculated double-stained cells as a
percentage of all analyzed endothelial cells or smooth muscle
cells, respectively. This analysis was based on 50 randomly chosen
GFP-positive cells as well as 15 vessels in the periinfarct region
and in the corresponding parts of the ipsilateral hemisphere.
TTC Staining
Tissue damage was evaluated by TTC. The brains were cut into
1-mm coronal slices with a vibratome (Campden Instruments,
752 M). Sections were incubated in 2% TTC 20min at 37◦C and
in 10% formalin overnight. The necrotic area site and extent in
each section were evaluated by image analysis software (Image-
Pro Plus) (Boscia et al., 2009) and expressed as a percentage
according to the following formula: area of the ischemic lesion:
area of hemisphere ipsilateral to the lesion= X:100.
NeuN Staining
Neuronal damage was evaluated by NeuN Staining. The brains
were cut into 1-mm coronal slices with a vibratome (Campden
Instruments, 752M). Slices were fixed at room temperature in 4%
paraformaldehyde in PBS for 30min. Briefly, slices were washed
four times in PBS, treated with 1% H2O2 in PBS for 5min,
washed three times in PBS and preincubated in PBS containing
3% bovine serum albumin and 0.1% Triton-X. Then, the sections
were incubated with the primary antibody anti-NeuN (1:2000)
at 4◦C overnight, washed six times in PBS and incubated with
the biotinylated secondary antibody (1:200; horse anti-mouse
IgG) for 2 h at room temperature. Next, they were washed in
PBS and processed with the Elite Vectastain avidin-biotin kit
(1:300; 1, 5 h). The peroxidase reaction was developed by 3-
3′-diaminobenzidine tetrahydrochloride as a chromogen. After
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the final wash, sections were dehydrated and coverslipped. The
necrotic area site and extent in each section were evaluated by
image analysis software (Image-Pro Plus) (Boscia et al., 2009;
Matute et al., 2013) and expressed as a percentage of the ipsilateral
hemisphere section area according to the following formula:
area of the ischemic lesion: area of hemisphere ipsilateral to the
lesion= X:100.
Neurological Assessment
All animals were subjected to a battery of behavioral tests before
MCAO and at different reperfusion times, using a modified
neurological severity score, as previously described by Chen et al.
(2001).
Statistical Analysis
All data were expressed as mean ± SEM. Data were tested
for normal distribution with the Kolmogorov–Smirnov test.
Parametric (Student’s t-tests, ANOVA and Bonferroni post-
hoc test) or non-parametric tests (Wilcoxon, Mann–Whitney,
and Kruskal–Wallis tests) were used; non-parametric tests
were applied to compare diameter and length data among
experimental groups. The statistical analysis was carried out by
SPSS 14.0 statistical package. Statistical significance was set at
p < 0.05.
Results
In sham-operated animals pial arteriolar networks showed the
same geometric characteristics when observed on left or right
parietal hemisphere. Pial arterioles, seldom organized in arcading
vessels (especially, order 2 and 1 arterioles), were classified
according to diameter, length, and branching (Table 1).
All rats submitted to the experimental procedure and MCAO
survived; therefore, we did not have any mortality.
In ischemic groups, we observed that the pial microcirculation
was progressively reorganized attaining full recovery at 28 days
of reperfusion: the capillary density significantly increased, while
microvascular permeability and leukocyte adhesion markedly
decreased, compared with animals observed at shorter times of
reperfusion (Lapi et al., 2013).
Effects of BM-MSCs Infusion at 1, 7, 14, and 28
Days of Reperfusion
BM-MSCs, injected after MCAO, were able to accelerate
remodeling processes. After 1 day of reperfusion BM-MSCs did
TABLE 1 | Diameter and length of each arteriolar order in sham-operated
animals.
Order Arteriole (n) Diameter (µm) Length (µm) Rats (n)
4 27 44.5 ± 0.7* 987 ± 250 9
3 78 34.0 ± 0.6* 481 ± 120 9
2 113 23.0 ± 0.5* 360 ± 100 9
1 109 15.5 ± 0.7* 140 ± 83 9
*p < 0.01 vs. different order.
not trigger any reorganization (Figures 1A,B) of pial arterioles,
while after 7 and 14 days of reperfusion, BM-MSCs stimulated
a complex geometric rearrangement of pial networks, compared
with the respective groups of ischemic rats untreated with
BM-MSCs (Figures 1C–F). Asymmetry was greater in larger
FIGURE 1 | Computer-assisted images of pial microvascular network
in a rat after 2 h MCAO and 1 day of reperfusion (I-1R group) (A), and in
a rat infused with GFP-BM-MSCs after 2 h MCAO and observed after 1
day of reperfusion (I-MSCs-1R group) (B). In (C) and in (E), computer-
assisted images of pial microvascular network in a rat subjected to 2 h MCAO
and observed at 7 or 14 days of reperfusion (I-7R and I-14R group),
respectively, and in a rat infused with GFP-BM-MSCs after 2 h MCAO and
observed after 7 or 14 days of reperfusion (I-MSCs-7R and I-MSCs-14R
group), respectively (D,F). In (G), computer- assisted images of pial
microvascular network in a rat subjected to 2 h MCAO and observed at 28
days of reperfusion (I-28R group), and in a rat infused with GFP-BM-MSCs
after 2 h MCAO and observed after 28 days of reperfusion (I-MSCs-28R
group) (H).
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TABLE 2 | Connectivity matrix with four orders of pial arterioles in
sham-operated group (A) and in contralateral hemisphere (B), in the
affected hemisphere in I-7R group (C), in the affected hemisphere in
I-MSCs-7R group (D).
(A)
Order n Order m
1 2 3 4
0 2.55 ± 0.37 (94) 0.37 ± 0.05 (12) 0 0
1 0.33 ± 0.16 (12) 2.10 ± 0.62 (67) 0.87 ± 0.15 (24) 0.53 ± 0.17 (6)
2 0 0.35 ± 0.12 (11) 2.05 ± 0.90 (57) 1.60 ± 1.00 (19)
3 0 0 0.45 ± 0.18 (13) 2.87 ± 1.05 (34)
4 0 0 0 0.18 ± 1.05 (2)
Order N
4 12
3 28
2 32
1 37
(B)
Order n Order m
1 2 3 4
0 2.32 ± 0.29 (83) 0.35 ± 0.07 (12) 0 0
1 0.29 ± 0.11 (10) 2.00 ± 0.55 (68) 0.91 ± 0.18 (27) 0.48 ± 0.09 (5)
2 0 0.37 ± 0.12 (13) 2.11 ± 0.75 (63) 1.63 ± 0.88 (18)
3 0 0 0.42 ± 0.16 (13) 2.87 ± 0.97 (32)
4 0 0 0 0.20 ± 0.11 (2)
Order N
4 11
3 30
2 34
1 36
(C)
Order n Order m
1 2 3 4
0 1.94 ± 0.30 (45) 0.70 ± 0.09 (13) 0 0
1 0.38 ± 0.14 (9) 0.89 ± 0.13 (16) 1.27 ± 0.25 (25) 0.31 ± 0.11 (2)
2 0 0.62 ± 0.17 (11) 0.25 ± 0.12 (5) 1.55 ± 0.42 (11)
3 0 0 0.36 ± 0.13 (7) 0.20 ± 0.08 (1)
4 0 0 0 0
Order N
4 7
3 20
2 18
1 23
(Continued)
TABLE 2 | Continued
(D)
Order n Order m
1 2 3 4
0 4.35 ± 0.32 (152) 1.60 ± 0.78 (43) 0 0
1 0.76 ± 0.12 (27) 3.80 ± 0.33 (103) 3.05 ± 0.90 (70) 0.95 ± 0.33 (9)
2 0 1.13 ± 0.85 (31) 4.52 ± 0.24 (104) 2.10 ± 0.34 (19)
3 0 0 0.50 ± 0.18 (12) 1.98 ± 0.26 (18)
4 0 0 0 0
Order N
4 9
3 23
2 27
1 35
N, Number of vessels studied for each order.
vessels, as confirmed by the connectivity matrix showing that
vessels of greater orders did not give rise to vessels of the
order immediately lower, as observed in sham operated animals
and in contralateral hemisphere (Tables 2A–D). The number of
penetrating pial arterioles was significantly increased compared
to the corresponding untreated groups.
Interstitial edema, quantified by fluorescent dextran leakage,
at 1 day was marked (0.38 ± 0.03 NGL, p = NS vs. I-1R),
while at 7 and 14 days, it was lower compared with the finding
in the corresponding groups untreated with BM-MSCs (0.27 ±
0.04 vs. 0.47 ± 0.02 NGL, p < 0.01 vs. I-7R group and
0.19 ± 0.03 vs. 0.40 ± 0.03 NGL, p < 0.01 vs. I-14R group,
respectively).
The number of adherent leukocytes after 1, 7, and 14 days
of reperfusion was 8.0 ± 0.1, 4.0 ± 0.3, and 3.0 ± 0.4/100µm
venular length/30 s, respectively (p < 0.01 vs. baseline and
I-1R, I-7R, and I-14R groups). The capillary density at 1 day
of reperfusion was significantly reduced, as observed in the
corresponding untreated group (47.0 ± 5.0 vs. 52.0 ± 4.3 cm−1,
p = NS vs. I-1R group). After 7 and 14 days of reperfusion the
capillary density was higher than in untreated groups (79 ± 5
vs. 67 ± 1 cm−1, p < 0.05 vs. I-7R group and 89 ± 4vs. 70.0
± 1.4 cm−1, p < 0.01 vs. I-14R group).
At 28 days of reperfusion (I-MSCs-28R group), pial networks
showed anastomotic vessels overlapping the ischemic core
(Figures 1G,H). The characteristics of each order of vessels,
described by the connectivity matrix, were different compared
to the arteriolar orders in sham operated animals, because of the
prevalence in anastomotic arterioles. Most of the order 2 vessels
originated anastomotic arterioles, causing a dramatic increase in
vessel anastomosis; while the order 1 vessels gave origin to most
capillaries overlapping the ischemic core.
At the same time, microvascular permeability and leukocyte
adhesion decreased (0.06 ± 0.03 vs. 0.20 ± 0.02 NGL, p < 0.05
vs. I-28R group and 0.9 ± 0.8 vs. 3.0 ± 0.2/100µm venular
lenght/30s, p < 0.05 vs. I-28R group, respectively). Capillary
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density was significantly increased, 123.0 ± 1.8 vs. 85.0 ±
1.2 cm−1, p < 0.05 vs. I-28R group).
The culture medium, injected after MCAO, was not able to
trigger the effects induced by BM-MSCs administration after 7 or
14 or 28 days of reperfusion.
The physiological parameters such as hematocrit, MABP,
heart rate, pH, PCO2, and PO2 did not change in the different
experimental groups.
VEGF, eNOS, nNOS, and iNOS Expression at 7,
14, and 28 Days of Reperfusion
We evaluated the expression of VEGF and the three different
NOS proteins in the ipsilesional (IPSI) temporoparietal cortex
and striatum of rats subjected to MCAO plus BM-MSCs
at different reperfusion time intervals: 7, 14, and 28 days
compared with the expression of the same proteins in untreated
rats.
We found that VEGF protein peaked at 7 days in the IPSI
cortex and striatum, while at 14 and 28 days of reperfusion
there was a decrease in the ischemic animals (Figure 2). The
same trend was detected for eNOS, p-eNOS, nNOS, and iNOS
expression (Figure 3).
VEGF, eNOS, and p-eNOS were higher in BM-MSCs
treated rats. Conversely, nNOS was minimally expressed at
7 days, decreasing afterward; while iNOS expression was
blunted.
FIGURE 2 | Western blotting of VEGF expression in the cortex and
striatum (CTX and STR) of sham-operated animals (S), of ischemic
(MCAO) untreated animals (UN CTX and UN STR), and of ischemic
treated animals (TR CTX and TR STR); the corresponding
densitometric values (mean ± SEM), expressed as arbitrary units
calculated for each experimental group, were normalized on the basis
of the respective β-tubulin. Each single experiment was repeated three
times. *p < 0.01 vs. S and respective ischemic group in cortex. ◦p < 0.01 vs.
S and respective ischemic group in striatum.
Evaluation of CD31-GFP, VWF-GFP, and
α-SMA-GFP Double Labeling
GFP-positive cells infused after MCA occlusion were observed
in all ischemic and penumbra areas, in close association with
blood vessels in pilot experiments. After 1 h of reperfusion GFP-
BM-MSCs were largely found in arterioles of the penumbra
area as observed in three rats utilized to assess the primary cell
localization, not reported in the experimental groups. Disruption
of the BBB after MCAO, as shown by microvascular permeability
increase, was accompanied by selective entry of BM-MSCs
into ischemic brain compared with non-ischemic contralateral
hemisphere. At 7 days, GFP-BM-MSCs were mainly found in
the damaged hemisphere. Moreover, these cells were organized in
penumbra area to form straight-like lines, suggesting a track for
tube-like vessel formation (Figure 4). In the last group of treated
animals, after 28 days of reperfusion marked fluorescence along
the vessel walls was observed with a reduced number of cells into
the penumbra area and interstitium.
In particular, confocal analysis detected most of the
GFP-BM-MSCs in close association with vessels at 7
days after infusion in ischemic animals (Figures 5, 6). To
investigate the cells phenotype of transplanted GFP-BM-MSCs
observed along vessels of the infarcted region, we performed
immunofluorescence experiments with selective endothelial
(Figure 5) or smooth muscle (Figure 5) cells markers. We
observed higher coexpression of GFP signal with CD31 or vWF
immunoreactivity, when compared to the cells coexpressing
both GFP signal and α-SMA labeling. The ratio was 4:1 between
CD31 or vWF and α-SMA. Our results indicate that most of the
GFP-BM-MSCs appear to express mainly CD31 or vWF (data
not shown) in the infarcted area (Figure 5).
Tissue Damage Evaluation by TTC or NeuN
Staining
Rats not subjected to BM-MSCs infusion showed a larger lesion
size in the cortex and striatum in the affected hemisphere
compared with the ipsilateral hemisphere in treated groups. At
7 days of reperfusion the ischemic animals (I-7R group) showed
a marked lesion, indicating neuronal loss, in the cortex and
striatum in the affected hemisphere (43.4± 2.5% of the ipsilateral
hemisphere; p < 0.01 vs. S group) compared with S group and
contralateral hemisphere. After 14 and 28 days of reperfusion the
lesions progressively decreased (35.0 ± 2.7 and 22.8 ± 3.0% of
the ipsilateral hemisphere, respectively; p < 0.01 vs. S and I-7R
groups, Figures 7A,B,D,F).
In the animals subjected to BM-MSCs infusion the lesion size
in the cortex and striatum was significantly reduced as early as at
7 days of reperfusion (32.3 ± 3.0% of the ipsilateral hemisphere,
p < 0.01 vs. I-7R and S groups). At 14 and 28 days of reperfusion
(I-MSCs-14R and I-MSCs-28R groups) the lesions in the cortex
and striatum were 15.5 ± 2.7 and 5.4 ± 1.5% of the ipsilateral
hemisphere, respectively (p < 0.01 vs. I-14R, I-28R, and S
groups) (Figures 7C,E,G).
The same trend in lesions was detected by NeuN staining for
the each reperfusion time. Rats subjected to 2 h of MCAO and
untreated with BM-MSCs showed a larger lesion size in the cortex
and striatum in the affected hemisphere compared with the
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FIGURE 3 | Western blotting of eNOS and phosphorilated eNOS
expression in the cortex and striatum (CTX and STR) of
sham-operated (S), ischemic (MCAO) untreated animals (UN CTX and
UN STR), and of ischemic treated animals (TR CTX and TR STR); the
corresponding densitometric values (mean ± SEM), expressed as
arbitrary units calculated for each experimental group, were
normalized on the basis of the respective β-tubulin. Each single
experiment was repeated three times. *p < 0.01 vs. S and respective
ischemic group in cortex. ◦p < 0.01 vs. S and respective ischemic group in
striatum.
ipsilateral hemisphere in treated groups. At 7 days of reperfusion
in the ischemic animals (I-7R group) the lesion size of the affected
hemisphere was 42.0 ± 3.6% of the ipsilateral hemisphere (p <
0.01 vs. S group), significantly different compared with S group
and contralateral hemisphere. After 14 and 28 days of reperfusion
the lesion size decreased (33.0 ± 3.0 and 21.5 ± 2.0% of the
ipsilateral hemisphere, respectively; p < 0.01 vs. S and I-7R
groups).
Infusion of BM-MSCs after 2 h of MCAO reduced the lesion
size in the cortex at 7 days of reperfusion (31.0 ± 2.5% of the
ipsilateral hemisphere, p < 0.01 vs. I-7R and S groups). At 14 and
28 days of reperfusion (I-MSCs-14R and I-MSCs-28R groups)
the lesion size in the cortex and striatum was 16.3 ± 3.0% and
3.5 ± 1.0% of the ipsilateral hemisphere, respectively (p < 0.01
vs. I-14R, I-28R, and S groups) (Figure 8).
In particular, the lesion size, highlighted by TTC or NeuN
staining was proportional to the neuronal damaged area.
Evaluation of Neurological Deficits by Behavioral
Test
No significant differences in the behavioral tests were detected
among the experimental groups before MCAO; the score was 0
(normal), as reported in Table 3. Increasing the reperfusion time
all animals treated with BM-MSCs showed a progressive decrease
in behavioral deficits compared with ischemic animals. The
recovery from damage was faster in BM-MSCs treated animals,
because the rats completely regained neurological functions
within 14 days of ischemia (I-MSCs-14R group): the score
was 1.0 ± 0.5, not significantly different compared to baseline
conditions. In ischemic animals the same results were observed
at 28 days of reperfusion after ischemia (Table 3).
Discussion
The present study demonstrates that intracarotid administration
of BM-MSCs induced faster rat pial microvascular remodeling
after MCAO. We compared the post-ischemic geometric re-
organization of arteriolar networks in treated and untreated
groups of animals up to 28 days of reperfusion. After 1
day of reperfusion BM-MSCs were detected into pial vessels;
the microvascular leakage due to the transient MCAO was
marked and no geometric rearrangement of pial networks
was observed. Interestingly, after 7 days of reperfusion, we
observed that in the BM-MSCs treated animals, remodeling
improved with formation of vessels observed in untreated rats
only at 14 days of reperfusion. To the same extent, at 14
days of reperfusion in the treated group, we detected similar
geometric characteristics observed after 28 days of reperfusion
in untreated animals. Therefore, we suggest that the role
of these cells was to accelerate the remodeling processes of
pial networks, with formation of new anastomotic vessels. An
increased number, indeed, of anastomotic arcading arterioles
characterized the pial microvasculature of all ischemic groups.
These arcades were likely vessels sprouting from preexistent
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FIGURE 4 | Computer-assisted image of pial microvascular network in
a rat subjected to 2h MCAO and infused with GFP-BM-MSCs and
observed after 1 day of reperfusion (I-MSCs-1R). GFP- BM-MSCs were
detected into the vessels, as indicated by the white arrow (A). In (B),
computer-assisted image of pial microvascular network in a rat subjected to
2 h MCAO and infused with GFP-BM-MSCs and observed after 7 days of
reperfusion (I-MSCs-7R). Interstitial fluorescent GFP-BM- MSCs were
organized to form straight lines as a track for new vessel formation (white
dashed line).
FIGURE 5 | Colocalization of CD31 (A) and GFP-signal (B) in the
infarcted region of a rat infused with GFP-BM-MSCs after 2h MCAO
and observed after 7 days of reperfusion (I-GFP-MSCs-7R group).
Control cells (C), merged (D).
FIGURE 6 | Colocalization of α-SMA (A) and GFP-signal (B) in the
infarcted region of a rat subjected to 2h MCAO, infused with
GFP-BM-MSCs and observed after 7 days of reperfusion
(I-GFP-MSCs-7R). Control cells (C), merged (D).
arterioles localized in the penumbra area, able to overlap the
ischemic core. The improvement in microvascular remodeling
processes might be related to the formation of cellular linear
guide for new vessel assembling, observed at 7 days of reperfusion
in BM-MSCs treated animals. Analysis of connectivity matrix,
indeed, demonstrates that arcading arterioles in order 2 and 1
vessels were predominant in the treated animals at 14 days of
reperfusion. These anastomotic vessels characterized all treated
animals at 28 days of reperfusion, demonstrating a complex and
intricate overlapping of new vessels on the previous ischemic
core.
Supporting our previous data (Golanov et al., 1994; Lapi
et al., 2013), VEGF, the most important mitogen in the process
of angiogenesis, promotes the vascular remodeling. Our results
indicated that BM-MSCs increase the expression of this protein
and induce other protein expression, playing an important role
in the remodeling mechanisms.
eNOS and p-eNOS expression peaked after 7 days of
reperfusion, while the iNOS expression decreased. This
effect triggered by cell transplantation caused a reduction in
inflammatory factor expression, helping minimize post-ischemic
inflammation and ischemic damage in the host brain, as
previously reported (Wei et al., 2012). nNOS is known to be
activated during the acute phase of experimental stroke (Wei
et al., 2012), but in our experiments nNOS was minimally
expressed at 7 days of reperfusion. Previous data, moreover,
indicate that the infarct volume after experimental stroke
significantly decreased in nNOS gene knockout or by nNOS
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FIGURE 7 | TTC staining of coronal brain slice from a rat submitted to
MCAO and 1 day of reperfusion. The lesion in the cortex and striatum is
outlined by the dashed black line (A). TTC staining of coronal brain slices from
a rat submitted to MCAO and 7 or 14 or 28 days of reperfusion (B,D,F). TTC
staining of coronal brain slices from a rat treated with BM-MSCs after MCAO,
at 7 or 14 or 28 days of reperfusion (C,E,G).
inhibition (Samdani et al., 1997; Willmot et al., 2005). Our
data show that nNOS expression in cortex and striatum was
reduced by treatment with BM-MSCs. Therefore, BM-MSCs
can provide a source of several trophic and growth factors,
playing important roles in angiogenesis as well as stimulating
differentiation of BM-MSCs (Chen et al., 2001; Kurozumi
et al., 2005). Another interesting finding of our study was the
identification and localization of GFP-BM-MSCs within vessels
in the infarcted area. Our data demonstrate that several GFP-BM-
MSCs colocalize with CD31 or vWF, while few GFP-BM-MSCs
appeared to colocalize with α-SMA. A proportional ratio of
these differentiated cells was 4:1 between cells expressing CD31
or vWF and α-SMA. Therefore, it is possible to hypothesize
that the phenotype of most GFP-BM-MSCs appears to be
preferentially oriented toward endothelial vascular cells. These
present results require further studies to complete the phenotype
characterization of these cells.
Improving in vascular remodeling accelerated by
BM-MSCs treatment was accompanied by reduction of
infarcted area in the affected hemisphere and by marked
FIGURE 8 | TTC and NeuN staining of coronal brain slices from rats
treated with BM-MSCs after MCAO at 1 day of reperfusion (A,B,
respectively); TTC and NeuN staining of coronal brain slices from rats
treated with BM-MSCs after MCAO at 7 (C,D, respectively), at 14 (E,F,
respectively), and 28 (G,H, respectively) days of reperfusion. The lesion
in the cortex and striatum is outlined by the dashed black line.
improvement in behavioral data from the battery of functional
tests.
Our data indicate that after ischemic insult the lesion size
in the cortex and striatum in the affected hemisphere was
progressively reduced, while the motor and sensory functions
gradually recovered. At 14 days of reperfusion these animals
presented the same neuronal damage observed in animals
untreated with BM-MSCs at 28 days of reperfusion. Moreover,
at 14 days of reperfusion the treated animals showed the same
score detected in animals untreated with BM-MSCs at 28 days
of reperfusion. Therefore, our data demonstrate a significant
improvement in motor and sensory functions in animals treated
with BM-MSCs. To determine the size of damaged areas, we
used the TTC or NeuN staining. We compared these sets of
data and we did not find significant differences between the
results obtained by both methods. The lesion sizes identified
by TTC and NeuN staining overlapped, demonstrating these
techniques were effective in precisely marking neuronal damaged
areas.
In conclusion, transient MCAO induced pial vascular
remodeling, characterized by arteriolar anastomotic arcades
able to overlap the ischemic core, supplying blood to
the neuronal tissue. This process improved by graft of
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TABLE 3 | Neurological severity score: one point is awarded for the inability to perform the tasks or for the lack of a tested reflex.
Sham-operated 1 day of 7 days of 14 days of 28 days of
reperfusion reperfusion reperfusion reperfusion
Point Point Point Point Point
I-R BM-MSCs I-R BM-MSCs I-R BM-MSCs I-R BM-MSCs
MOTOR TEST
Flexion of forelimb 0 1 1 1 0 1 0 0 0
Flexion of hindlimb 0 1 1 1 0 1 0 0 0
Head moving more than 10◦ (vertical axis) 0 1 1 1 1 1 0 0 0
Placing the rat on the floor 0 1 1 1 1 1 0 0 0
Inability to walk straight 0 1 1 1 1 1 0 0 0
Circling toward the paretic side 0 1 1 1 1 1 0 0 0
Falling down to the paretic side 0 1 1 1 0 0 0 0 0
Abnormal movements 0 1 1 1 0 0 0 0 0
Immobility and staring 0 0 0 0 0 0 0 0 0
Tremor (wet-dog shakes) 0 0 0 0 0 0 0 0 0
Myodystony, irritability, seizures 0 1 1 1 1 1 1 1 0
SENSORY TEST
Visual and tactile placing 0 1 1 1 1 1 0 0 0
Proprioceptive test (deep sensory) 0 1 0 0 0 0 0 0 0
Reflexes (blunt or sharp stimulation) absent of:
Pinna reflex (a head shake when touching the
auditory meatus)
0 1 1 0 0 0 0 0 0
Corneal reflex (an eye blink when lightly
touching the cornea with cotton)
0 1 1 0 0 0 0 0 0
Startle reflex (a motor response to a brief loud
paper noise)
0 0 0 0 0 0 0 0 0
Maximum points 0 13 ± 0.4 12 ± 0.5 10 ± 0.5 6 ± 0.5 8 ± 0.4 1 ± 0.5 1 ± 0.5 0
Score: 10–14 severe; 5–9 moderate; 1–4 mild injury.
BM-MSCs able to increase the speed of microvascular
remodeling through formation of arcading arterioles. These
anastomotic vessels originated from the preexistent arterioles
in penumbra area, finally overlapping the ischemic core.
This mechanism of accelerated new vessel formation was
accompanied by higher expression of vascular trophic
factors, such as VEGF, eNOS, and p-eNOS, known to
modulate in vivo angiogenesis. The cerebral microvascular
remodeling specifically corresponded to improved neurological
functions.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fncel.
2015.00329
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